We provide you with 20 years of free, institutional-grade data for MIRA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MIRA. Explore the full financial landscape of MIRA stock.
| Reported Date | CIK | Ticker | Type |
|---|
MIRA Pharmaceuticals, Inc.(NASDAQ:MIRA) 
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitiv...
Website: https://www.mirapharmaceuticals.com/
Founded: 2020
IPO Price: $7 (Aug 03, 2023)
CEO: Erez Aminov
Sector: ...
Industry: Pharmaceuticals
Share this website to your friends
The information provided in this report about MIRA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.